Sectors & IndustriesHealthcareHealthcare Plans

Best Healthcare Plan Stocks to Buy Now (2025)

Top healthcare plan stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best healthcare plan stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare plan stocks to buy right now are:

Cigna Group (NYSE:CI) is the #1 top healthcare plan stock out of 11 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Cigna Group (NYSE:CI) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: A.

Cigna Group (NYSE:CI) has a Due Diligence Score of 49, which is 8 points higher than the healthcare plan industry average of 41.

CI passed 18 out of 38 due diligence checks and has strong fundamentals. Cigna Group has seen its stock lose -1.75% over the past year, overperforming other healthcare plan stocks by 24 percentage points.

Cigna Group has an average 1 year price target of $377.77, an upside of 18.15% from Cigna Group's current stock price of $319.75.

Cigna Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Cigna Group, 69.23% have issued a Strong Buy rating, 23.08% have issued a Buy, 7.69% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Cvs Health (NYSE:CVS) is the #2 top healthcare plan stock out of 11 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Cvs Health (NYSE:CVS) is: Value: C, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: C, and AI: B.

Cvs Health (NYSE:CVS) has a Due Diligence Score of 20, which is -21 points lower than the healthcare plan industry average of 41. Although this number is below the industry average, our proven quant model rates CVS as a "B".

CVS passed 8 out of 38 due diligence checks and has weak fundamentals. Cvs Health has seen its stock return 18.92% over the past year, overperforming other healthcare plan stocks by 45 percentage points.

Cvs Health has an average 1 year price target of $76.75, an upside of 13.82% from Cvs Health's current stock price of $67.43.

Cvs Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Cvs Health, 50% have issued a Strong Buy rating, 33.33% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Humana (NYSE:HUM) is the #3 top healthcare plan stock out of 11 with a Zen Rating of B. Stocks with a rating of B have had an average return of +19.88% per year. Learn more.

The Component Grade breakdown for Humana (NYSE:HUM) is: Value: B, Growth: C, Momentum: D, Sentiment: B, Safety: C, Financials: B, and AI: B.

Humana (NYSE:HUM) has a Due Diligence Score of 37, which is -4 points lower than the healthcare plan industry average of 41. Although this number is below the industry average, our proven quant model rates HUM as a "B".

HUM passed 12 out of 38 due diligence checks and has average fundamentals. Humana has seen its stock lose -33.95% over the past year, underperforming other healthcare plan stocks by -8 percentage points.

Humana has an average 1 year price target of $288.50, an upside of 20.37% from Humana's current stock price of $239.68.

Humana stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Humana, 8.33% have issued a Strong Buy rating, 25% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 4 healthcare plan stocks that have issued dividends in the past year, the 3 healthcare plan stocks with the highest dividend yields are:

Unitedhealth Group (NYSE:UNH) has an annual dividend yield of 2.76%, which is 1 percentage points higher than the healthcare plan industry average of 1.82%. Unitedhealth Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Unitedhealth Group's dividend has shown consistent growth over the last 10 years.

Unitedhealth Group's dividend payout ratio of 34.9% indicates that its dividend yield is sustainable for the long-term.

Elevance Health (NYSE:ELV) has an annual dividend yield of 1.92%, which is the same as the healthcare plan industry average of 1.82%. Elevance Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Elevance Health's dividend has shown consistent growth over the last 10 years.

Elevance Health's dividend payout ratio of 25.6% indicates that its dividend yield is sustainable for the long-term.

Cigna Group (NYSE:CI) has an annual dividend yield of 1.35%, which is the same as the healthcare plan industry average of 1.82%. Cigna Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cigna Group's dividend has shown consistent growth over the last 10 years.

Cigna Group's dividend payout ratio of 31.4% indicates that its dividend yield is sustainable for the long-term.

Healthcare plan stocks were down -0.34% in the last day, and down -6.27% over the last week.

We couldn't find a catalyst for why healthcare plan stocks are down.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare plan stocks right now are:

Centene (NYSE:CNC) is the most undervalued healthcare plan stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Centene has a valuation score of 57, which is 31 points higher than the healthcare plan industry average of 26. It passed 4 out of 7 valuation due diligence checks.

Centene's stock has dropped -50.1% in the past year. It has underperformed other stocks in the healthcare plan industry by -24 percentage points.

Molina Healthcare (NYSE:MOH) is the second most undervalued healthcare plan stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Molina Healthcare has a valuation score of 43, which is 17 points higher than the healthcare plan industry average of 26. It passed 3 out of 7 valuation due diligence checks.

Molina Healthcare's stock has dropped -19.17% in the past year. It has overperformed other stocks in the healthcare plan industry by 7 percentage points.

Elevance Health (NYSE:ELV) is the third most undervalued healthcare plan stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Elevance Health has a valuation score of 57, which is 31 points higher than the healthcare plan industry average of 26. It passed 4 out of 7 valuation due diligence checks.

Elevance Health's stock has dropped -34.42% in the past year. It has underperformed other stocks in the healthcare plan industry by -8 percentage points.

50% of healthcare plan stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare plan stocks to rise by 32.85% over the next year.

10% of healthcare plan stocks have a Zen Rating of A (Strong Buy), 40% of healthcare plan stocks are rated B (Buy), 50% are rated C (Hold), 0% are rated D (Sell), and 0% are rated F (Strong Sell).